Publication
  • JSH 2026 •
  • 9 October, 2026 •
  • •

A phase 3 study in Japan of avatrombopag for chronic immune thrombocytopenia: final analysis

Masaki Iino, Hiroki Yamaguchi, Jun Yamanouchi, Harumi Kamiya, Helena Ahlin, Pooja Iyer, Nina Skuban, Yoshiaki Tomiyama

Available materials

Oral Presentation
Symposium
  • EHA •
  • 13 June, 2026 •
  • •

From Labs to Lives: Redefining Success in Rare Diseases Paroxysmal Nocturnal Haemoglobinuria (PNH) and Chronic Immune Thrombocytopenia (ITP)

Danny Hsu, Ana Boban, María L Lozano

Available materials

Video
Publication
  • EHA •
  • 13 June, 2026 •
  • •

Avatrombopag in TPO RA–naive adults in acute, persistent, and chronic phases of ITP: results from the REAL AVA 3.0 retrospective study

Sandhya Panch, Abiola Oladapo, Faizan Sattar, Michael Vredenburg , Sarah Lucht, Emily Bland, Prathamesh Pathak, Bruce Feinberg, Debbie Jiang

Available materials

Poster
Publication
  • EHA •
  • 12 June, 2026 •
  • •

Impact of protocol mandated dose holds on platelet response durability in pediatric ITP treated with avatrombopag: AVA 301 post hoc analysis

Rachael F. Grace, Göksel Leblebisatan, Yesim Aydinok, Şule Ünal, John Grainger, Amanda Grimes, Michele Lambert, Jessica Zhang, Brian D. Jamieson, Chelsea Bernheisel, Michael Vredenburg , Faizan Sattar

Available materials

Oral Presentation
Sign up for alerts